Mesa Laboratories, Inc. (MLAB)

NASDAQ: MLAB · Real-Time Price · USD

124.76

+5.61 (4.71%)

At close: Aug 21, 2026, 4:00 PM EDT

124.70

-0.06 (-0.05%)

After-hours: Aug 21, 2026, 7:35 PM EDT

Mesa Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	4.8	6.71	-1.97	-254.25	0.93	1.87
Depreciation & Amortization	22.96	23.27	24.53	31.57	33.13	25.07
Asset Writedown & Restructuring Costs	-	-	-	274.53	-	-
Stock-Based Compensation	16.35	17.87	13.14	11.94	12.54	11.39
Other Operating Activities	5.68	-0.03	4.21	-25.64	-1.51	8.09
Change in Accounts Receivable	3.14	-3.21	-2.93	4.94	-2.12	-6.75
Change in Inventory	-2.68	-4.43	1.15	2.56	-10.18	-1.05
Change in Accounts Payable	1.02	-1.2	-0.39	-0.1	-1.55	1.37
Change in Unearned Revenue	-0.48	-0.26	-0.94	-0.41	0.61	2.59
Change in Other Net Operating Assets	4.9	4.11	10	-1.03	-3.87	-3.35
Operating Cash Flow	55.67	42.83	46.81	44.13	27.98	39.22
Operating Cash Flow Growth	46.67%	-8.50%	6.06%	57.71%	-28.66%	5.80%

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Capital Expenditures	-2.8	-3.25	-4.25	-2.57	-4.54	-4.43
Cash Acquisitions	-	-	-	-78.74	-4.95	-300.79
Sale (Purchase) of Intangibles	-	-	-0.25	-	-	-
Investing Cash Flow	-2.8	-3.25	-4.5	-81.31	-9.49	-305.23

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Long-Term Debt Issued	-	107.5	73.47	71	-	70
Long-Term Debt Repaid	-	-134.25	-115.81	-33.5	-36	-21
Net Debt Issued (Repaid)	-38.47	-26.75	-42.35	37.5	-36	49
Issuance of Common Stock	-	-	2.64	0.36	7	8.03
Repurchase of Common Stock	-0.96	-1.06	-0.89	-0.73	-0.92	-0.88
Common Dividends Paid	-3.53	-3.52	-3.47	-3.45	-3.41	-3.34
Other Financing Activities	-0.97	-10.52	-0.45	-0.85	-	-0.24
Financing Cash Flow	-43.93	-41.85	-44.51	32.84	-33.33	52.58

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Foreign Exchange Rate Adjustments	0.47	1.88	1.31	-0.36	-1.6	-1.09
Net Cash Flow	9.42	-0.39	-0.89	-4.7	-16.44	-214.52

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Free Cash Flow	52.87	39.58	42.56	41.57	23.44	34.79
Free Cash Flow Growth	57.40%	-7.00%	2.39%	77.34%	-32.63%	-0.83%
Free Cash Flow Margin	21.17%	15.89%	17.66%	19.23%	10.70%	18.87%
Free Cash Flow Per Share	9.41	7.11	7.85	7.72	4.37	6.52
Levered Free Cash Flow	53.38	31.88	60.43	47.35	24.33	11.18
Unlevered Free Cash Flow	60.17	38.57	67.85	50.91	27.31	13.6

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash Interest Paid	10.02	10.02	11.08	4.65	3.49	2.76
Cash Income Tax Paid	1.87	1.87	5.73	4.59	1.36	3.05
Change in Working Capital	5.89	-4.99	6.9	5.97	-17.11	-7.19

SEC Filings: 10-K · 10-Q